Hila Karah Net Worth

The estimated Net Worth of Hila Karah is at least $79.8 Тысяча dollars as of 16 October 2020. Ms. Karah owns over 1,372 units of DarioHealth Corp stock worth over $38,823 and over the last 9 years she sold DRIO stock worth over $0. In addition, she makes $41,000 as Independent Director at DarioHealth Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Karah DRIO stock SEC Form 4 insiders trading

Hila has made over 11 trades of the DarioHealth Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently she bought 1,372 units of DRIO stock worth $1,084 on 16 October 2020.

The largest trade she's ever made was buying 34,166 units of DarioHealth Corp stock on 9 July 2019 worth over $26,991. On average, Hila trades about 3,700 units every 53 days since 2016. As of 16 October 2020 she still owns at least 49,143 units of DarioHealth Corp stock.

You can see the complete history of Ms. Karah stock trades at the bottom of the page.

Hila Karah biography

Hila Karah serves as Independent Director of the Company. Ms. Karah is an independent business consultant and an investor in several high-tech, biotech and internet companies. From 2006 to 2013, she served as a partner and Chief Investment Officer of Eurotrust Ltd., a family office. From 2002 to 2005, she served as a research analyst at Perceptive Life Sciences Ltd., a New York-based hedge fund. Prior to that, Ms. Karah served as research analyst at Oracle Partners Ltd., a health care-focused hedge fund. Ms. Karah has served as a director in several private and public companies including Intec Pharma, since 2009 and Cyren Ltd since 2008. Ms. Karah holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley, and studied at the University of California, Berkeley-University of California, San Francisco Joint Medical Program.

What is the salary of Hila Karah?

As the Independent Director of DarioHealth Corp, the total compensation of Hila Karah at DarioHealth Corp is $41,000. There are 8 executives at DarioHealth Corp getting paid more, with Erez Raphael having the highest compensation of $1,382,200.

How old is Hila Karah?

Hila Karah is 51, she's been the Independent Director of DarioHealth Corp since 2014. There are 8 older and 8 younger executives at DarioHealth Corp. The oldest executive at DarioHealth Corp is Richard Stone, 77, who is the Independent Director.

What's Hila Karah's mailing address?

Hila's mailing address filed with the SEC is 322 W 57TH ST, #33B18, , NEW YORK, NY, 10019.

Insiders trading at DarioHealth Corp

Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern и Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.

What does DarioHealth Corp do?

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.

Complete history of Ms. Karah stock trades at CYREN Ltd, DarioHealth Corp и Intec Parent Inc

DarioHealth Corp executives and stock owners

DarioHealth Corp executives and other stock owners filed with the SEC include:

• Erez Raphael,
  Chief Executive Officer, Director
• Erez Raphael,
  CEO & Director
• Richard A. Anderson,
  Pres & GM of North America
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben-David,
  Chief Financial Officer, Treasurer, Secretary
• Olivier Jarry,
  Senior Vice President - Strategy and Business Development
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben David,
  CFO, Treasurer & Sec.
• Richard Stone,
  Independent Director
• Dennis McGrath,
  Independent Director
• Hila Karah,
  Independent Director
• Dennis Matheis,
  Director
• Omar Manejwala,
  Chief Medical Officer
• Barbara Stark,
  Senior Vice President, Head of Managed Markets
• Adam Stern,
  Director
• Yadin Shemmer,
  Independent Director
• Richard Anderson,
  President, General Manager - North America
• Allen Kamer,
  Independent Director
• Yoav Shaked,
  Independent Chairman of the Board
• Limor Drezner,
  VP HR & Chief of Staff
• Josh Fischer,
  Sr. VP of Operations & Compliance
• Yinon Amir,
  Head of Software Innovation
• Jean Christophe Muyl,
  Head of Commercialization North America
• Suzanne Bedell,
  VP of Marketing
• Claudia Levi,
  Content & Communications Mang.
• Dov Oppenheim,
  Co-Founder & Production Chief
• Olivier R. Jarry,
  Sr. VP of Strategy & Bus. Devel.
• Hod Rami Yehudiha,
  Director
• Glen Moller,
  Director
• Yalon Farhi,
  Director
• Malcolm Hoenlein,
  Director
• Ori Zanco,
  Director
• Yossi Bahagon,
  Director
• Shmuel Farhi,
  10% owner
• Yossef Balucka,
  CEO and President
• Oded Cohen,
  GM MSK
• Jon H. Kaplan,
  Director
• Tomer Ben Kiki,
  Chief Operating Officer
• Steven Charles Nelson,
  Chief Commercial Officer